RxDoctor Payments Data

Anthony Foto, DO

Family Medicine · Concord, NCNPI 1396851218

Payments from drug & device makers

$475in general payments, 2019–2025

Across 36 payments — averaging $13.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$121
  • Antares Pharma, Inc.$60
  • Amarin Pharma, Inc.$54
  • AstraZeneca$52
  • Pfizer$40
  • Neos Therapeutics, LP$28
  • plus $121 from 8 others

What the payments were for

  • Food & beverage$475100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$475 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$175,064
Medicare patients
658
Services billed
1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban493$147,742
AustedoDeutetrabenazine17$63,965
TrulicityDulaglutide92$51,849
XareltoRivaroxaban137$39,496
JardianceEmpagliflozin78$24,437
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$21,856
XifaxanRifaximin17$20,150
LinzessLinaclotide36$19,894
JanuviaSitagliptin Phosphate62$17,797
Lagevrio (Eua)Molnupiravir17$17,181
Combivent RespimatIpratropium/Albuterol Sulfate28$14,774
MyrbetriqMirabegron56$14,127
RexultiBrexpiprazole19$13,526
ArexvyRsvpref3 Antigen/As01e/Pf42$13,277
Divalproex Sodium128$10,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$40$155,927519 claims
Lilly USA, LLCTrulicity, Mounjaro$14$58,127114 claims
MerckJanuvia, Lagevrio (Eua)$12$34,97879 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$15$20,15017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Concord

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →